loadpatents
Patent applications and USPTO patent grants for Orbe Lopategui; Josune.The latest application filed is for "new antifibrinolytic compounds".
Patent | Date |
---|---|
Antifibrinolytic compounds Grant 9,440,989 - Orbe Lopategui , et al. September 13, 2 | 2016-09-13 |
New Antifibrinolytic Compounds App 20150175618 - Orbe Lopategui; Josune ;   et al. | 2015-06-25 |
Use of matrix metalloproteinase-10 (MMP-10) for thrombolytic treatments Grant 8,541,370 - Orbe Lopategui , et al. September 24, 2 | 2013-09-24 |
Methods for anti-fibrinolytic treatment using MMP-10 neutralizing antibody Grant 8,257,701 - Orbe Lopategui , et al. September 4, 2 | 2012-09-04 |
Use Of Matrix Metalloproteinase-10 (mmp-10) For Thrombolytic Treatments App 20110091436 - Orbe Lopategui; Josune ;   et al. | 2011-04-21 |
Compositions For Anti-fibrinolytic Treatment App 20100135986 - Orbe Lopategui; Josune ;   et al. | 2010-06-03 |
Use Of Matrix Metalloproteinase-10 (mmp-10) For Thrombolytic Treatments App 20100040596 - Orbe Lopategui; Josune ;   et al. | 2010-02-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.